MRC1 and glioblastoma: Four tumors presented MSS with MMR germline mutations and lack of expression of the associated protein; one glioblastoma with MSI-L showed two mutations in the MSH2 gene, one mutation in the MLH1 gene and loss of MLH1, MSH2 and MSH6 protein expression.